<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37202167</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1526-632X</ISSN><JournalIssue CitedMedium="Internet"><Volume>101</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>04</Day></PubDate></JournalIssue><Title>Neurology</Title><ISOAbbreviation>Neurology</ISOAbbreviation></Journal><ArticleTitle>Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis.</ArticleTitle><Pagination><StartPage>e83</StartPage><EndPage>e93</EndPage><MedlinePgn>e83-e93</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1212/WNL.0000000000207367</ELocationID><Abstract><AbstractText Label="BACKGROUND AND OBJECTIVES">Despite recent advances, it is not clear whether the various genes/genetic variants related to amyotrophic lateral sclerosis (ALS) interact in modifying patients' phenotype. The aim of this study was to determine whether the copresence of genetic variants related to ALS has interactive effects on the course of the disease.</AbstractText><AbstractText Label="METHODS">The study population includes 1,245 patients with ALS identified through the Piemonte Register for ALS between 2007 and 2016 and not carrying superoxide dismutase type 1, TAR DNA binding protein, and fused in sarcoma pathogenic variants. Controls were 766 Italian participants age-matched, sex-matched, and geographically matched to cases. We considered Unc-13 homolog A (<i>UNC13A</i>) (rs12608932), calmodulin binding transcription activator 1 (<i>CAMTA1</i>) (rs2412208), solute carrier family 11 member 2 (<i>SLC11A2</i>) (rs407135), and zinc finger protein 512B (<i>ZNF512B</i>) (rs2275294) variants, as well as ataxin-2 (<i>ATXN2</i>) polyQ intermediate repeats (&#x2265;31) and chromosome 9 open reading frame 72 (<i>C9orf72</i>) GGGGCC intronic expansions (&#x2265;30).</AbstractText><AbstractText Label="RESULTS">The median survival time of the whole cohort was 2.67 years (interquartile range [IQR] 1.67-5.25). In univariate analysis, only <i>C9orf72</i> (2.51 years, IQR 1.74-3.82; <i>p</i> = 0.016), <i>ATXN2</i> (1.82 years, IQR 1.08-2.33; <i>p</i> &lt; 0.001), and <i>UNC13A</i> <sup>C/C</sup> (2.3 years, IQR 1.3-3.9; <i>p</i> &lt; 0.001) significantly reduced survival. In Cox multivariable analysis, <i>CAMTA1</i> also emerged to be independently related to survival (hazard ratio 1.13, 95% CI 1.001-1.30, <i>p</i> = 0.048). The copresence of 2 detrimental alleles/expansions was correlated with shorter survival. In particular, the median survival of patients with <i>CAMTA1</i> <sup>G/G+G/T</sup> and <i>UNC13A</i> <sup>C/C</sup> alleles was 1.67 years (1.16-3.08) compared with 2.75 years (1.67-5.26) of the patients not carrying these variants (<i>p</i> &lt; 0.001); the survival of patients with <i>CAMTA1</i> <sup>G/G+G/T</sup> alleles and <i>ATXN2</i> <sup>&#x2265;31</sup> intermediate polyQ repeats was 1.75 years (0.84-2.18) (<i>p</i> &lt; 0.001); the survival of patients with <i>ATXN2</i> <sup>&#x2265;31</sup> polyQ repeats and <i>UNC13A</i> <sup>C/C</sup> allele was 1.33 years (0.84-1.75) (<i>p</i> &lt; 0.001); the survival of patients with <i>C9ORF72</i> <sup>&#x2265;30</sup> and <i>UNC13A</i> <sup>C/C</sup> allele was 1.66 years (1.41-2.16). Each pair of detrimental alleles/expansions was associated to specific clinical phenotypes.</AbstractText><AbstractText Label="DISCUSSION">We showed that gene variants acting as modifiers of ALS survival or phenotype can act on their own or in unison. Overall, 54% of patients carried at least 1 detrimental common variant or repeat expansion, emphasizing the clinical impact of our findings. In addition, the identification of the interactive effects of modifier genes represents a crucial clue for explaining ALS clinical heterogeneity and should be considered when designing and interpreting clinical trials results.</AbstractText><CopyrightInformation>Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a &#x201c;work of the United States Government&#x201d; for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chi&#xf2;</LastName><ForeName>Adriano</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy. adriano.chio@unito.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moglia</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Canosa</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manera</LastName><ForeName>Umberto</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grassano</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-6714-6897</Identifier><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasta</LastName><ForeName>Rosario</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palumbo</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-7070-2409</Identifier><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallone</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brunetti</LastName><ForeName>Maura</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barberis</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7458-5174</Identifier><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Marchi</LastName><ForeName>Fabiola</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-4366-0167</Identifier><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalgard</LastName><ForeName>Clifton</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2025-8239</Identifier><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chia</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-4709-7423</Identifier><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mora</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-8388-2373</Identifier><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iazzolino</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peotta</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Traynor</LastName><ForeName>Bryan J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corrado</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Alfonso</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzini</LastName><ForeName>Letizia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>From the "Rita Levi Montalcini" Department of Neuroscience (A. Chi&#xf2;, C.M., A. Canosa, U.M., M.G., R.V., F.P., S.G., M. Brunetti, G.M., B.I., L.P., A. Calvo), University of Turin; Neurology 1 (A. Chi&#xf2;, C.M., A. Canosa, U.M., S.G., M. Barberis, A. Calvo), AOU Citt&#xe0; della Salute e della Scienza Hospital of Turin; Institute of Cognitive Sciences and Technologies (A. Chi&#xf2;, A. Canosa), CNR, Rome; ALS Center (F.D.M., L.M.), Department of Neurology, Maggiore della Carit&#xe0; Hospital, University of Piemonte Orientale, Novara, Italy; Department of Anatomy, Physiology &amp; Genetics (C.D.), and The American Genome Center (C.D.), Uniformed Services University of the Health Sciences; Neuromuscular Diseases Research Section (R.C., B.J.T.), Laboratory of Neurogenetics, National Institute on Aging, Bethesda; Department of Neurology (B.J.T.), Johns Hopkins University Medical Center, Baltimore, MD; and Department of Health Sciences (L.C., S.D.A., L.M.), University of Eastern Piedmont, Novara, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Z01 AG000949</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurology</MedlineTA><NlmUniqueID>0401060</NlmUniqueID><ISSNLinking>0028-3878</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>A. Chi&#xf2; serves on scientific advisory boards for Mitsubishi Tanabe, Biogen, Roche, Denali Pharma, Cytokinetics, Lilly, and Amylyx Pharmaceuticals and has received a research grant from Biogen. C. Moglia, A. Canosa, U. Manera, M. Grassano, R. Vasta, F. Palumbo, S. Gallone, M. Brunetti, F. De Marchi, C.L. Dalgard, R. Chia, G. Mora, L. Corrado, S. D'Alfonso, and L. Mazzini report no disclosures. B.J. Traynor holds the US, Canadian, and European patents on the clinical testing and therapeutic intervention for the hexanucleotide repeat expansion in C9orf72. A. Calvo has received a research grant from Cytokinetics. Go to Neurology.org/N for full disclosures.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>19</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>18</Day><Hour>21</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37202167</ArticleId><ArticleId IdType="pmc">PMC10351316</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000207367</ArticleId><ArticleId IdType="pii">WNL.0000000000207367</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vasta R, Chia R, Traynor BJ, Chi&#xf2; A. Unraveling the complex interplay between genes, environment, and climate in ALS. EBioMedicine. 2022;75:103795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8728044</ArticleId><ArticleId IdType="pubmed">34974309</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman SA, Hardiman O, Al-Chalabi A, et al. . Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol. 2022;21(5):480-493.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9513753</ArticleId><ArticleId IdType="pubmed">35334233</ArticleId></ArticleIdList></Reference><Reference><Citation>Diekstra FP, van Vught PW, van Rheenen W, et al. . UNC13A is a modifier of survival in amyotrophic lateral sclerosis. Neurobiol Aging. 2012;33(3):630.e3-630.e8.</Citation><ArticleIdList><ArticleId IdType="pubmed">22118904</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Mora G, Restagno G, et al. . UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study. Neurobiol Aging. 2013;34(1):357.e1-357.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3483408</ArticleId><ArticleId IdType="pubmed">22921269</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogh I, Lin K, Tiloca C, et al. . Association of a locus in the CAMTA1 gene with survival in patients with sporadic amyotrophic lateral sclerosis. JAMA Neurol. 2016;73(7):812-820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5556366</ArticleId><ArticleId IdType="pubmed">27244217</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Moglia C, et al. . ATXN2 polyQ intermediate repeats are a modifier of ALS survival. Neurology. 2015;84(3):251-258.</Citation><ArticleIdList><ArticleId IdType="pubmed">25527265</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Moglia C, Canosa A, et al. . Exploring the phenotype of Italian patients with ALS with intermediate ATXN2 polyQ repeats. J Neurol Neurosurg Psychiatry. 2022;93(11):1216-1220. doi:10.1136/jnnp-2022-329376</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2022-329376</ArticleId><ArticleId IdType="pmc">PMC9606535</ArticleId><ArticleId IdType="pubmed">36008116</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Vourc'h P, Nadjar Y, et al. ; French ALS study group. Association between divalent metal transport 1 encoding gene (SLC11A2) and disease duration in amyotrophic lateral sclerosis. J Neurol Sci. 2011;303(1-2):124-127.</Citation><ArticleIdList><ArticleId IdType="pubmed">21276595</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Yang B, Wang F, et al. . Association of single nucleotide polymorphism at rs2275294 in the ZNF512B gene with prognosis in amyotrophic lateral sclerosis. Neuromolecular Med. 2021;23(2):242-246.</Citation><ArticleIdList><ArticleId IdType="pubmed">33387304</ArticleId></ArticleIdList></Reference><Reference><Citation>van Eijk RPA, Jones AR, Sproviero W, et al. . Meta-analysis of pharmacogenetic interactions in amyotrophic lateral sclerosis clinical trials. Neurology. 2017;89(18):1915-1922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5664299</ArticleId><ArticleId IdType="pubmed">28978660</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Mora G, Moglia C, et al. . Secular trends of amyotrophic lateral sclerosis: the Piemonte and Valle d'Aosta Register. JAMA Neurol. 2017;74(9):1097-1104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5710181</ArticleId><ArticleId IdType="pubmed">28692730</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Mazzini L, et al. . Extensive genetics of ALS: a population-based study in Italy. Neurology 2012;79(19):1983-1989.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3484987</ArticleId><ArticleId IdType="pubmed">23100398</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1(5):293-299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassano M, Calvo A, Moglia C, et al. . Mutational analysis of known ALS genes in an Italian population-based cohort. Neurology. 2021;96(4):e600-e609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7905787</ArticleId><ArticleId IdType="pubmed">33208543</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R, Sabir MS, Bandres-Ciga S, et al. . Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat Genet. 2021;53(3):294-303. doi:10.1038/s41588-021-00785-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00785-3</ArticleId><ArticleId IdType="pmc">PMC7946812</ArticleId><ArticleId IdType="pubmed">33589841</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Abrahams S, Goldstein LH, et al. . Amyotrophic lateral sclerosis&#x2013;frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener 2017;18(3-4):153-174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Iazzolino B, Peotta L, Zucchetti JP, et al. . Differential neuropsychological profile of patients with amyotrophic lateral sclerosis with and without C9orf72 mutation. Neurology. 2021;96(1):e141-e152.</Citation><ArticleIdList><ArticleId IdType="pubmed">33106391</ArticleId></ArticleIdList></Reference><Reference><Citation>Berdy&#x144;ski M, Miszta P, Safranow K, et al. . SOD1 mutations associated with amyotrophic lateral sclerosis analysis of variant severity. Sci Rep. 2022;12(1):103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8742055</ArticleId><ArticleId IdType="pubmed">34996976</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M, Mullen B, Wojtas A, et al. . Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene. Mol Neurodegener. 2014;9(1):38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4190282</ArticleId><ArticleId IdType="pubmed">25239657</ArticleId></ArticleIdList></Reference><Reference><Citation>Dekker AM, Seelen M, van Doormaal PT, et al. . Large-scale screening in sporadic amyotrophic lateral sclerosis identifies genetic modifiers in C9orf72 repeat carriers. Neurobiol Aging. 2016;39:220.e9-220.e15.</Citation><ArticleIdList><ArticleId IdType="pubmed">26777436</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Moglia C, Canosa A, et al. . ALS phenotype is influenced by age, sex, and genetics: a population-based study. Neurology. 2020;94(8):e802-e810.</Citation><ArticleIdList><ArticleId IdType="pubmed">31907290</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo A, Canosa A, Bertuzzo D, et al. . Influence of cigarette smoking on ALS outcome: a population-based study. J Neurol Neurosurg Psychiatry. 2016;87(11):1229-1233.</Citation><ArticleIdList><ArticleId IdType="pubmed">27656044</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbohm A, Peter R, Dorst J, et al. . Life course of physical activity and risk and prognosis of amyotrophic lateral sclerosis in a German ALS Registry. Neurology. 2021;97(19):e1955-e1963.</Citation><ArticleIdList><ArticleId IdType="pubmed">34670816</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandres-Ciga S, Noyce AJ, Hemani G, et al. . Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann Neurol. 2019;85(4):470-481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6450729</ArticleId><ArticleId IdType="pubmed">30723964</ArticleId></ArticleIdList></Reference><Reference><Citation>Boddy SL, Giovannelli I, Sassani M, et al. . The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS). BMC Med. 2021;19(1):13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7816375</ArticleId><ArticleId IdType="pubmed">33468103</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura R, Kurihara M, Ogawa N, et al. . Investigation of the prognostic predictive value of serum lipid profiles in amyotrophic lateral sclerosis: roles of sex and hypermetabolism. Sci Rep. 2022;12(1):1826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8814149</ArticleId><ArticleId IdType="pubmed">35115598</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetsuka S, Morita M, Iida A, Uehara R, Ikegawa S, Nakano I. ZNF512B gene is a prognostic factor in patients with amyotrophic lateral sclerosis. J Neurol Sci. 2013;324(1-2):163-166. doi:10.1016/j.jns.2012.10.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2012.10.029</ArticleId><ArticleId IdType="pubmed">23168171</ArticleId></ArticleIdList></Reference><Reference><Citation>Neelagandan N, Gonnella G, Dang S, et al. . TDP-43 enhances translation of specific mRNAs linked to neurodegenerative disease. Nucleic Acids Res. 2019;47(1):341-361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6326785</ArticleId><ArticleId IdType="pubmed">30357366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma XR, Prudencio M, Koike Y, et al. . TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A. Nature. 2022;603(7899):124-130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8891019</ArticleId><ArticleId IdType="pubmed">35197626</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown AL, Wilkins OG, Keuss MJ, et al. . TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature. 2022;603(7899):131-137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8891020</ArticleId><ArticleId IdType="pubmed">35197628</ArticleId></ArticleIdList></Reference><Reference><Citation>Brichta L, Shin W, Jackson-Lewis V, et al. . Identification of neurodegenerative factors using translatome-regulatory network analysis. Nat Neurosci. 2015;18(9):1325-1333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4763340</ArticleId><ArticleId IdType="pubmed">26214373</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorenson EJ, Mandrekar J, Crum B, Stevens JC. Effect of referral bias on assessing survival in ALS. Neurology. 2007;68(8):600-602.</Citation><ArticleIdList><ArticleId IdType="pubmed">17310031</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Marin B, Piccininni M, et al. . Referral bias in ALS epidemiological studies. PLoS One. 2018;13(4):e0195821.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901916</ArticleId><ArticleId IdType="pubmed">29659621</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>